Review
[Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis]
[Article in
Danish]
Affiliations
- PMID: 17355841
Item in Clipboard
Review
[Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis]
[Article in
Danish]
Ugeskr Laeger.
.
Abstract
Recently published studies have demonstrated that infliximab is effective not only in Crohn's disease, but also in ulcerative colitis. The present article reviews current treatment options for severe ulcerative colitis as well as available data on the effect of infliximab in the treatment of this disease. The article discusses the possible future role of infliximab in the treatment of ulcerative colitis.
Similar articles
-
A review of infliximab use in ulcerative colitis.Clin Ther. 2008 Feb;30(2):223-30. doi: 10.1016/j.clinthera.2008.02.014. Clin Ther. 2008. PMID: 18343261 Review.
-
Infliximab for the treatment of ulcerative colitis.Expert Rev Gastroenterol Hepatol. 2009 Jun;3(3):219-29. doi: 10.1586/egh.09.19. Expert Rev Gastroenterol Hepatol. 2009. PMID: 19485804
-
Current management of severe ulcerative colitis.Nat Clin Pract Gastroenterol Hepatol. 2007 Feb;4(2):92-101. doi: 10.1038/ncpgasthep0687. Nat Clin Pract Gastroenterol Hepatol. 2007. PMID: 17268544 Review.
-
Infliximab in the treatment of steroid-dependent ulcerative colitis.Eur Rev Med Pharmacol Sci. 2004 Sep-Oct;8(5):231-3. Eur Rev Med Pharmacol Sci. 2004. PMID: 15638236 Clinical Trial.
-
Colectomy rate in acute severe ulcerative colitis in the infliximab era.Dig Liver Dis. 2008 Oct;40(10):821-6. doi: 10.1016/j.dld.2008.03.014. Epub 2008 May 9. Dig Liver Dis. 2008. PMID: 18472316
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical